Inao T, Yokota I. Comparison of sequential test for binary outcome. Japanese Classification Society2021 symposium, Okinawa, Japan, Dec 12, 2021. Okura H, Inao T, Yokota I. Estimation of restricted mean survival time for interval-censored data usingmidpoint imputation. Japanese Classification Society 2021 symposium, Okinawa, Japan, Dec 11, 2021.
Dr. Isao Yokota e-published a new paper as the first author in Travel Med Infect Dis.
Yokota I, Shane PY, Teshima T. Logistic advantage of two-step screening strategy for SARS-CoV-2 at airport quarantine. Travel Med Infect Dis. 2021: 102127. doi: 10.1016/j.tmaid.2021.102127. Epub ahead of print.
IY, KO, YU and YY from our lab e-published a new paper in Lancet Microbe.
Yokota I, Shane PY, Okada K, Unoki Y, Yang Y, Iwasaki S, Fujisawa S, Nishida M, Teshima T. A novel strategy for SARS-CoV-2 mass screening with quantitative antigen testing of saliva: a diagnostic accuracy study. Lancet Microbe. doi: 10.1016/S2666-5247(21)00092-6 Press releasehttps://www.global.hokudai.ac.jp/blog/a-rapid-antigen-test-for-sars-cov-2-in-saliva/
Dr. Isao Yokota e-published a new paper as the first author in Sci Rep.
Yokota I, Hattori T, Shane PY, Konno S, Nagasaka A, Takeyabu K, Fujisawa S, Nishida M, Teshima T. Equivalent SARS-CoV-2 viral loads by PCR between nasopharyngeal swab and saliva in symptomatic patients. Sci Rep. 2021;11:4500.